Vincenzo Iaconianni
Founder and CEO of ICMED S.r.l.
With over twenty years of direct experience in stem cell transplantation, cell and gene therapy, Vincenzo Iaconianni is recognised as one of the foremost international experts in healthcare accreditation and quality management systems.
He founded ICMED S.r.l. in 2017 with a clear vision: to build an integrated ecosystem where consulting, training, technology and research work in synergy to elevate healthcare quality standards globally.
Under his leadership, ICMED has supported over 41 healthcare facilities across 5 countries in achieving and maintaining JACIE/FACT, CNT/CNS, ISO 15189, GMP and GCP accreditations — with a 100% success rate in inspections.
He conceived and developed IAAPP, the proprietary AI-powered quality management platform, and founded ICMED Magazine (ISSN 3103-1943), the bilingual quarterly scientific journal dedicated to healthcare quality and innovation.
A regular speaker at EBMT (European Society for Blood and Marrow Transplantation) and ASH (American Society of Hematology) congresses, he is author of over 12 scientific publications in international journals including Bone Marrow Transplantation (Nature), Frontiers in Immunology, Journal of Clinical Apheresis and Blood.